Interact to see
Advertisement
Advertisement
ECDCX vs MEDAX
ECDCX vs MEDAX Comparison
Open Charts ECDCX vs MEDAX
Ashmore Emerging Mkts Corp Inc C
Price$5.48
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets20.02M
MFS Emerging Markets Debt A
Price$12.27
Change+$0.01 (+0.08%)
VolumeN/A
Net Assets7.37B
ECDCX vs MEDAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ECDCX vs. MEDAX commentary
Aug 02, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECDCX is a Sell and MEDAX is a Hold.
FUNDAMENTALS
Fundamentals
MEDAX has more cash in the bank: 7.37B vs. ECDCX (20M). MEDAX (5.63) and ECDCX (5.43) have matching dividends . ECDCX was incepted earlier than MEDAX: ECDCX (14 years) vs MEDAX (27 years). ECDCX (2.43) is less costly to investors than MEDAX (1.07). ECDCX is a more actively managed with annual turnover of: 95.00 vs. MEDAX (58.00). ECDCX (1000) and MEDAX (1000) have matching initial minimum investment requirements. MEDAX annual gain was more profitable for investors over the last year : 7.52 vs. ECDCX (5.78). MEDAX return over 5 years is better than : 8.58 vs. ECDCX (-4.20).
| ECDCX | MEDAX | ECDCX / MEDAX | |
| Total Expense Ratio | 1.94 | 1.06 | 183% |
| Annual Report Gross Expense Ratio | 2.43 | 1.07 | 227% |
| Fund Existence | 14 years | 27 years | - |
| Gain YTD | 3.983 | 5.259 | 76% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 20M | 7.37B | 0% |
| Annual Yield % from dividends | 5.43 | 5.63 | 96% |
| Returns for 1 year | 5.78 | 7.52 | 77% |
| Returns for 3 years | 17.91 | 25.46 | 70% |
| Returns for 5 years | -4.20 | 8.58 | -49% |
| Returns for 10 years | 20.77 | 38.86 | 53% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement